Stay updated with breaking news from Knott David. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Shares of Zymeworks Inc. (NYSE:ZYME – Get Rating) have been given an average recommendation of “Buy” by the nine brokerages that are currently covering the firm, Marketbeat.com reports. Two analysts have rated the stock with a hold rating and six have given a buy rating to the company. The average 12 month price objective among […]
Read the latest stock market news on MarketBeat. Get real-time analyst ratings, dividend information, earnings results, financials, headlines, insider trades and options data for any stock.
Read the latest stock market news on MarketBeat. Get real-time analyst ratings, dividend information, earnings results, financials, headlines, insider trades and options data for any stock.
Read the latest stock market news on MarketBeat. Get real-time analyst ratings, dividend information, earnings results, financials, headlines, insider trades and options data for any stock.
Iovance Biotherapeutics, Inc. (NASDAQ:IOVA – Get Rating) – Analysts at Truist Financial decreased their FY2023 earnings per share (EPS) estimates for Iovance Biotherapeutics in a research note issued on Wednesday, April 6th. Truist Financial analyst A. Goonewardene now forecasts that the biotechnology company will earn ($2.17) per share for the year, down from their prior […]